Humana Inc. (HUM) 10-Year Financial Performance & Capital Metrics

HUM • • Insurance & Managed Care

HealthcareHealth InsuranceMedicare Advantage SpecialistsTraditional Medicare Advantage

AboutHumana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Show more

Revenue $117.76B +10.7%
Combined Ratio 98.54% +1.8%
Net Income $1.21B -51.5%
Return on Equity 7.37% -53.1%
Medical Cost Ratio 0%
Operating Margin 1.46% -54.0%
Net Margin 1.02% -56.2%
ROA 2.58% -53.3%
Equity / Assets 35.38% +2.0%
Book Value per Share 136.06 +3.8%
Tangible BV/Share 44.44 +9.0%
Debt/Equity 0.71 -0.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓13 consecutive years of dividend growth
✓Share count reduced 2.9% through buybacks

✗Weaknesses

✗Profits declining 14.9% over 5 years

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y9.28%

5Y12.66%

3Y12.34%

TTM9.87%

Profit (Net Income) CAGR

10Y0.51%

5Y-14.92%

3Y-25.62%

TTM-5%

EPS CAGR

10Y3.09%

5Y-13.07%

3Y-23.93%

TTM-5.58%

ROCE

10Y Avg10.92%

5Y Avg8.43%

3Y Avg6.45%

Latest3.68%

Peer Comparison

Traditional Medicare Advantage

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HUMHumana Inc.	34.15B	283.95	28.45	10.7%	1.02%	6.95%	7%	0.71

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	54.29B	54.38B	53.77B	56.91B	64.89B	77.16B	83.06B	92.87B	106.37B	117.76B
Revenue Growth %	0.12%	0%	-0.01%	0.06%	0.14%	0.19%	0.08%	0.12%	0.15%	0.11%
Medical Costs & Claims+	0	0	0	0	0	0	0	0	0	0
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	54.29B	54.38B	53.77B	56.91B	64.89B	77.16B	83.06B	92.87B	106.37B	117.76B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	0.12%	0%	-0.01%	0.06%	0.14%	0.19%	0.08%	0.12%	0.15%	0.11%
Operating Expenses+	51.86B	52.83B	49.75B	54.85B	61.43B	72.56B	79.71B	89.3B	102.99B	116.04B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	447M	465M	485M	534M	575M	616M	713M	845M	917M	968M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	2.43B	1.55B	4.02B	2.06B	3.46B	4.6B	3.35B	3.57B	3.38B	1.72B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	0.12%	-0.36%	1.59%	-0.49%	0.68%	0.33%	-0.27%	0.06%	-0.05%	-0.49%
EBITDA+	2.88B	2.02B	4.5B	2.6B	4.03B	5.22B	4.07B	4.41B	4.3B	2.69B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	186M	189M	242M	218M	242M	283M	326M	401M	493M	660M
Non-Operating Income	-186M	-189M	-242M	-218M	-242M	-283M	-326M	-401M	-493M	-660M
Pretax Income+	2.43B	1.55B	4.02B	2.06B	3.46B	4.67B	3.42B	3.56B	3.32B	1.63B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	1.16B	938M	1.57B	391M	763M	1.31B	485M	762M	836M	413M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	1.28B	614M	2.45B	1.68B	2.71B	3.37B	2.93B	2.81B	2.49B	1.21B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	0.11%	-0.52%	2.99%	-0.31%	0.61%	0.24%	-0.13%	-0.04%	-0.11%	-0.52%
EPS (Diluted)+	8.44	4.07	16.81	12.16	20.10	25.31	22.67	22.08	20.00	9.98
EPS Growth %	0.15%	-0.52%	3.13%	-0.28%	0.65%	0.26%	-0.1%	-0.03%	-0.09%	-0.5%
EPS (Basic)	8.54	4.11	16.94	12.24	20.19	25.47	22.79	22.20	20.09	10.01
Diluted Shares Outstanding	151.14M	150.92M	145.58M	138.4M	134.73M	133.01M	129.4M	127.09M	124.44M	120.87M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	24.68B	25.4B	27.18B	25.41B	29.07B	34.97B	44.36B	43.05B	47.06B	46.48B
Asset Growth %	0.05%	0.03%	0.07%	-0.06%	0.14%	0.2%	0.27%	-0.03%	0.09%	-0.01%
Total Investment Assets+	1.84B	2.2B	2.75B	11.48B	12.44B	14.94B	14.11B	15.01B	17.75B	19.33B
Long-Term Investments	1.84B	2.2B	2.75B	11.48B	12.44B	14.94B	14.11B	15.01B	17.75B	19.33B
Short-Term Investments	0	0	0	0	10.97B	12.55B	13.19B	13.88B	16.63B	18.21B
Total Current Assets+	2.57B	3.88B	4.04B	2.34B	0	0	0	0	0	0
Cash & Equivalents	2.57B	3.88B	4.04B	2.34B	4.05B	4.67B	3.39B	5.06B	4.69B	2.22B
Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	-1.16B	-1.28B	-854M	-1.01B	-16.08B	-18.36B	-18.4B	-20.62B	-23.36B	-23.14B
Goodwill & Intangibles+	3.76B	3.67B	3.61B	4.14B	4.11B	4.78B	13.73B	10.91B	11.24B	11.07B
Goodwill	3.27B	3.27B	3.28B	3.9B	3.93B	4.45B	11.09B	9.14B	9.55B	9.63B
Intangible Assets	492M	399M	329M	245M	177M	329M	2.64B	1.76B	1.69B	1.44B
PP&E (Net)	1.38B	1.5B	1.58B	1.74B	1.96B	2.37B	3.07B	3.22B	3.03B	2.53B
Other Assets	16.97B	16.34B	17.94B	17.19B	-18.5B	-22.08B	-30.92B	-29.14B	-32.02B	-32.94B
Total Liabilities	14.33B	14.71B	17.34B	15.25B	17.04B	21.24B	28.25B	27.68B	30.75B	30.03B
Total Debt+	4.09B	4.09B	4.92B	6.07B	5.67B	6.66B	12.49B	11.13B	11.66B	11.72B
Net Debt	1.52B	215M	878M	3.73B	1.61B	1.99B	9.1B	6.07B	6.96B	9.5B
Long-Term Debt	3.79B	3.79B	4.77B	4.38B	4.97B	6.06B	10.54B	7.93B	10.21B	11.14B
Short-Term Debt	299M	300M	150M	1.69B	699M	600M	1.95B	3.19B	1.44B	577M
Total Current Liabilities+	0	7.82B	9.41B	10.08B	0	0	0	0	0	0
Accounts Payable	0	0	0	0	9.76B	12.16B	12.8B	14.5B	16.81B	15.7B
Deferred Revenue	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	-964M	7.03B	9.12B	7.93B	-10.68B	-13.08B	-15.08B	-17.99B	-18.61B	-16.68B
Deferred Taxes	0	0	0	0	0	0	0	0	0	0
Other Liabilities	-4.16B	-4.07B	-5.15B	-4.66B	-5.21B	-6.38B	-10.79B	-8.22B	-10.48B	-11.4B
Total Equity+	10.35B	10.69B	9.84B	10.16B	12.04B	13.73B	16.1B	15.37B	16.32B	16.45B
Equity Growth %	0.07%	0.03%	-0.08%	0.03%	0.18%	0.14%	0.17%	-0.05%	0.06%	0.01%
Shareholders Equity	10.35B	10.69B	9.84B	10.16B	12.04B	13.73B	16.08B	15.31B	16.26B	16.38B
Minority Interest	0	0	0	0	0	0	23M	59M	56M	70M
Retained Earnings	11.02B	11.45B	13.67B	15.07B	17.48B	20.52B	23.09B	25.49B	27.54B	28.32B
Common Stock	33M	33M	33M	33M	33M	33M	33M	33M	33M	33M
Accumulated OCI	58M	-66M	19M	-159M	156M	391M	42M	-1.3B	-999M	-1.07B
Return on Equity (ROE)	0.13%	0.06%	0.24%	0.17%	0.24%	0.26%	0.2%	0.18%	0.16%	0.07%
Return on Assets (ROA)	0.05%	0.02%	0.09%	0.06%	0.1%	0.11%	0.07%	0.06%	0.06%	0.03%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.40x	0.38x	0.50x	0.60x	0.47x	0.49x	0.78x	0.72x	0.71x	0.71x
Book Value per Share	68.45	70.80	67.60	73.42	89.34	103.21	124.45	120.93	131.13	136.06
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	868M	1.94B	4.05B	2.17B	5.28B	5.64B	2.26B	4.59B	3.98B	2.97B
Operating CF Growth %	-0.46%	1.23%	1.09%	-0.46%	1.43%	0.07%	-0.6%	1.03%	-0.13%	-0.25%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	1.28B	614M	2.45B	1.68B	2.71B	3.37B	2.93B	2.8B	2.49B	1.21B
Depreciation & Amortization	447M	465M	485M	534M	575M	616M	713M	845M	917M	968M
Stock-Based Compensation	109M	115M	157M	137M	163M	181M	180M	216M	175M	207M
Deferred Taxes	-2M	-71M	132M	194M	162M	195M	15M	-100M	-167M	-192M
Other Non-Cash Items	-346M	66M	141M	792M	14M	-863M	-1.02B	290M	486M	615M
Working Capital Changes	-616M	747M	688M	-1.17B	1.66B	2.14B	-556M	534M	81M	154M
Cash from Investing+	320M	-1.36B	-2.94B	-3.09B	-1.28B	-3.06B	-6.56B	-1.01B	-3.49B	-2.95B
Capital Expenditures	-523M	-527M	-526M	-612M	-736M	-964M	-1.34B	-1.14B	-1B	-575M
Acquisitions	1.02B	-7M	-31M	-2.25B	542M	-709M	-4.19B	2.36B	-233M	-89M
Purchase of Investments	-6.74B	-6.57B	-6.26B	-4.69B	-6.36B	-9.13B	-7.2B	-6.05B	-7.55B	-8.19B
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	1M	-828M	2M	-2.12B	-542M	0	26M	17M	210M	-461M
Cash from Financing+	-552M	732M	-945M	-785M	-2.29B	-1.96B	3.02B	-1.91B	-856M	-2.49B
Dividends Paid	-172M	-177M	-220M	-265M	-291M	-323M	-354M	-392M	-431M	-431M
Share Repurchases	-385M	-104M	-3.37B	-1.09B	-1.07B	-1.82B	-79M	-2.1B	-1.57B	-817M
Stock Issued	0	0	0	0	0	0	0	0	0	0
Debt Issuance (Net)	1000K	0	1000K	1000K	-1000K	1000K	1000K	-1000K	1000K	1000K
Other Financing	-260M	1.01B	1.89B	-595M	-511M	-890M	-310M	1.97B	725M	-1.46B
Net Change in Cash+	636M	1.31B	165M	-1.7B	1.71B	619M	-1.28B	1.67B	-367M	-2.47B
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	1.94B	2.57B	3.88B	4.04B	2.34B	4.05B	4.67B	3.39B	5.06B	4.69B
Cash at End	2.57B	3.88B	4.04B	2.34B	4.05B	4.67B	3.39B	5.06B	4.69B	2.22B
Free Cash Flow+	345M	1.41B	3.52B	1.56B	4.55B	4.67B	920M	3.45B	2.98B	2.39B
FCF Growth %	-0.68%	3.08%	1.5%	-0.56%	1.91%	0.03%	-0.8%	2.75%	-0.14%	-0.2%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	2.28	9.34	24.21	11.28	33.76	35.15	7.11	27.15	23.92	19.78

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	95.52%	97.15%	92.52%	96.38%	94.67%	94.04%	95.96%	96.16%	96.82%	98.54%
Medical Cost Ratio	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Return on Equity (ROE)	12.77%	5.84%	23.85%	16.83%	24.39%	26.14%	19.66%	17.83%	15.71%	7.37%
Return on Assets (ROA)	5.29%	2.45%	9.31%	6.4%	9.94%	10.51%	7.39%	6.42%	5.52%	2.58%
Equity / Assets	41.92%	42.07%	36.21%	39.98%	41.4%	39.26%	36.3%	35.7%	34.67%	35.38%
Book Value / Share	68.45	70.8	67.6	73.42	89.34	103.21	124.45	120.93	131.13	136.06
Debt / Equity	0.40x	0.38x	0.50x	0.60x	0.47x	0.49x	0.78x	0.72x	0.71x	0.71x
Revenue Growth	11.94%	0.17%	-1.13%	5.85%	14.01%	18.9%	7.66%	11.81%	14.54%	10.7%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Insurance	-	-	-	-	-	-	-	88.84B	102.85B	113.76B
Insurance Growth	-	-	-	-	-	-	-	-	15.77%	10.61%
CenterWell	-	-	-	-	-	-	-	17.31B	18.41B	19.94B
CenterWell Growth	-	-	-	-	-	-	-	-	6.34%	8.32%
Retail	-	-	-	-	-	67.3B	74.04B	-	-	-
Retail Growth	-	-	-	-	-	-	10.02%	-	-	-
Healthcare Services	23.61B	25.12B	23.96B	23.81B	25.78B	28.45B	31.24B	-	-	-
Healthcare Services Growth	-	6.43%	-4.63%	-0.61%	8.28%	10.34%	9.82%	-	-	-
Group And Specialty	-	-	7.45B	7.68B	7.53B	7.29B	6.87B	-	-	-
Group And Specialty Growth	-	-	-	3.09%	-2.01%	-3.19%	-5.67%	-	-	-
Individual Commercial	-	-	951M	8M	-	-	-	-	-	-
Individual Commercial Growth	-	-	-	-99.16%	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Humana Inc. (HUM) has a price-to-earnings (P/E) ratio of 28.5x. This suggests investors expect higher future growth.

Growth & Financials

Humana Inc. (HUM) grew revenue by 10.7% over the past year. This is steady growth.

Yes, Humana Inc. (HUM) is profitable, generating $1.29B in net income for fiscal year 2024 (1.0% net margin).

Dividend & Returns

Yes, Humana Inc. (HUM) pays a dividend with a yield of 1.26%. This makes it attractive for income-focused investors.

Humana Inc. (HUM) has a return on equity (ROE) of 7.4%. This is below average, suggesting room for improvement.

Industry Metrics

Humana Inc. (HUM) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.

US Stock Screener

...